Exocrine Pancreas Carcinoma (DBCOND0168332)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
- Not Available
- Clinical Trials
Identifier Title Drug(s) Purpose Phase Status NCT05554367 Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment Trial treatment 2 recruiting NCT06651580 Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study No drug interventions Not Available Not Available recruiting NCT02465060 Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - ABSK-091
- Adavosertib
- Afatinib
- Binimetinib
- Capivasertib
- Copanlisib
- Crizotinib
- Dabrafenib
- Dasatinib
- Defactinib
- Erdafitinib
- GSK-2636771
- Ipatasertib
- Larotrectinib
- Methane
- Nivolumab
- Osimertinib
- Palbociclib
- Pertuzumab
- Relatlimab
- Sapanisertib
- Sulfate ion
- Sunitinib
- Taselisib
- Trametinib
- Trastuzumab
- Trastuzumab emtansine
- Tyrosine
- Ulixertinib
- Vismodegib
screening 2 active_not_recruiting